(Q78080716)
Statements
Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model (English)
T Yamamoto
F Arakawa
K Nakamura
T Senba
Y Tomita
S Ikeda